Phase I Study to Evaluate the Diagnostic Performance of 89Zirconium Girentuximab PET in Urothelial Cancer Patients
Clinical trial NCT05046665 · COMPLETED
Trial details
- NCT number
- NCT05046665
- Sponsor
- South Metropolitan Health Service
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-14
- Primary completion
- 2022-08-09
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.